Literature DB >> 12185385

Toxicity to sea urchin egg development of the quinone fraction obtained from Auxemma oncocalyx.

L V Costa-Lotufo1, M A D Ferreira, T L G Lemos, O D L Pessoa, G S B Viana, G M A Cunha.   

Abstract

Auxemma oncocalyx Taub. belongs to the Boraginaceae family and is native to the Brazilian northeast where it is known as "pau-branco". We investigated the ability of the water soluble fraction isolated from the heartwood of A. oncocalyx to inhibit sea urchin egg development. This fraction contains about 80% oncocalyxone A (quinone fraction), a compound known to possess strong cytotoxic and antitumor activities. In fact, the quinone fraction inhibited cleavage in a dose-dependent manner [IC50 of 18.4 (12.4-27.2) microg/ml, N = 6], and destroyed the embryos in the blastula stage [IC50 of 16.2 (13.7-19.2) microg/ml, N = 6]. We suggest that this activity is due to the presence of oncocalyxone A. In fact, these quinones present in A. oncocalyx extract have strong toxicity related to their antimitotic activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185385     DOI: 10.1590/s0100-879x2002000800010

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.

Authors:  M A D Ferreira; N R F do Nascimento; C M de Sousa; O D L Pessoa; T L G de Lemos; J S Ventura; M Schattner; A M Chudzinski-Tavassi
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

2.  Magnetic nanosystem for cancer therapy using oncocalyxone a, an antitomour secondary metabolite isolated from a Brazilian plant.

Authors:  Antônio C H Barreto; Vivian R Santiago; Rafael M Freire; Selma E Mazzetto; Juliano C Denardin; Giuseppe Mele; Igor M Cavalcante; Maria E N P Ribeiro; Nágila M P S Ricardo; Tamara Gonçalves; Luigi Carbone; Telma L G Lemos; Otília D L Pessoa; Pierre B A Fechine
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.